Where does Korea Research Institute OF Bioscience AND Biotechnology rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Korea Research Institute OF Bioscience AND Biotechnology ranks #2,330 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Korea Research Institute OF Bioscience AND Biotechnology's patent grant rate increasing or decreasing?

Korea Research Institute OF Bioscience AND Biotechnology's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Korea Research Institute OF Bioscience AND Biotechnology's patents?

Korea Research Institute OF Bioscience AND Biotechnology's patents average 9.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Korea Research Institute OF Bioscience AND Biotechnology

Q: How many patents does Korea Research Institute OF Bioscience AND Biotechnology hold?

Korea Research Institute OF Bioscience AND Biotechnology holds 168 US utility patents granted between 2015 and 2025, spanning 53 technology areas.

Q: What is Korea Research Institute OF Bioscience AND Biotechnology's Innovation Score?

Korea Research Institute OF Bioscience AND Biotechnology has an Innovation Score of 50.8 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: What technology areas does Korea Research Institute OF Bioscience AND Biotechnology focus on?

Korea Research Institute OF Bioscience AND Biotechnology's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 92 patents, ranking #211 of 7,163 assignees active in that subclass. Grants appear in 53 CPC subclasses total.

Q: How is the Korea Research Institute OF Bioscience AND Biotechnology patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 168 granted patents across 53 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Korea ranks #2,330 of 49,997 tracked US assignees by granted-patent volume, with 168 patents across 53 technology areas.

#2,330
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.8/100): 9.3
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2330 · Foreign Corporation #2,330 · 168 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 168 grants
TOP-DECILE #2,330/49,997
PHOTO-FINISH Extreme Networks
CPC-WIDE A61K · 53 areas
INNOV-PAR 50.8/100
CLAIMS-PAR 9.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Extreme Networks, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Korea’s 50.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.7 pts (35%) Velocity 2.5 pts (5%) Breadth 25.0 pts (49%) Claim depth 5.6 pts (11%)

Qualcomm Incorporated · highest

85
BorgWarner Ludwigsburg · near

51
Chatsworth Products · near

51
Korea Research… · this assignee

51
Kurita Water… · near

51
Tamura · near

51
3D Lighting… · lowest

7

What this shows Korea's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Korea?

Each dot is one of Korea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Korea’s own 9.3 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Korea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Korea's grant cadence moved

Between 2020–2024, Korea Research Institute OF Bioscience AND Biotechnology received 35 grants versus 119 in 2015–2019 (-71% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 29 grants and bottomed in 2022 at 4. Lead class A61K accounts for 54.8% of the portfolio across 53 subclasses. Volume neighbours: Extreme Networks, Inc. (#2,326) and Oerlikon Surface Solutions AG, Pfäffikon (#2,334).

Korea's three-year grant acceleration

From 2019–2021 to 2022–2024, Korea Research Institute OF Bioscience AND Biotechnology moved from 38 to 14 grants (0.37x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,918. See the growth leaderboard.

Extreme Networks

168
General Electric…

168
Ingersoll-rand In…

168
Intellectual Vent…

168
Magna Exteriors

168
NLT

168
Netronome Systems

168
Oerlikon Surface…

168
Korea Research In… ◀

168

What this shows Korea holds 168 patents at rank #2,330, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Korea

By rank, the assignees closest to #2,330 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Korea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Korea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Korea ranks #211 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Tamura Corporation 51 Kurita Water Industries Ltd. 51 Chatsworth Products, Inc. 51 BorgWarner Ludwigsburg GmbH 51

Similar claim depth

Nearest assignees by average claims per patent (9.3 here).

Adeka Corporation 9.3 avg Sintokogio, Ltd. 9.3 avg Max Co., Ltd. 9.3 avg Kawasaki Jukogyo Kabushiki Kaisha 9.3 avg

Korea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Korea Research Institute OF Bioscience AND Biotechnology patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	29	17.3%
2016	26	15.5%
2017	26	15.5%
2018	21	12.5%
2019	17	10.1%
2020	13	7.7%
2021	8	4.8%
2022	4	2.4%
2023	5	3.0%
2024	5	3.0%
2025partial year	14	8.3%

Which technologies does Korea Research Institute OF Bioscience AND Biotechnology patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 92

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 83

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 61

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 36

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 34

C07K - Peptides 33

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 22

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 19

C12Y - Enzymes 17

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 15

C07D - Heterocyclic Compounds 15

C07C - Acyclic OR Carbocyclic Compounds 9

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 8

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 8

A23K - Fodder 8

Top 15 of 53 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Korea Research Institute OF Bioscience AND Biotechnology's patent record in context - here's where to go next.

Korea Research Institute OF Bioscience AND Biotechnology's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 54.8% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #2,330 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Korea Research Institute OF Bioscience AND Biotechnology against Extreme Networks, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.